Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression

Neuropharmacology

Volumn 58, Issue 4-5, 2010, Pages 730-738

  Hollis, Jacob H ^a   Lemus, Moyra ^a   Evetts, Megan J ^a   Oldfield, Brian J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MELANIN CONCENTRATING HORMONE; OREXIN; PROTEIN FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEVER; FOOD INTAKE; HYPOPHAGIA; HYPOTHALAMUS; LUNG GAS EXCHANGE; MALE; METABOLIC REGULATION; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EATING; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HYPOTHALAMUS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; NEUROPEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 77649339778     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.12.016     Document Type: Article

References (107)

1. Akiyama M., Yuasa T., Hayasaka N., Horikawa K., Sakurai T., Shibata S. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice. Eur. J. Neurosci. 2004, 20:3054-3062.
2. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001, 7:167.
3. Alon T., Friedman J.M. Late-onset leanness in mice with targeted ablation of melanin concentrating hormone neurons. J. Neurosci. 2006, 26:389-397.
4. Becskei C., Riediger T., Hernadfalvy N., Arsenijevic D., Lutz T.A., Langhans W. Inhibitory effects of lipopolysaccharide on hypothalamic nuclei implicated in the control of food intake. Brain Behav. Immun. 2008, 22:56-64.
5. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995, 96:2339-2347.
6. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L., Vale W., Sawchenko P.E. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 1992, 319:218-245.
7. Bluthe R.M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., Michaud B., Kelley K.W., Dantzer R. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 1999, 24:301.
8. Bret-Dibat J.L., Bluthe R.M., Kent S., Kelley K.W., Dantzer R. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav. Immun. 1995, 9:242.
9. Buchanan J.B., Peloso E., Satinoff E. Thermoregulatory and metabolic changes during fever in young and old rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R1165-R1169.
10. Burdakov D., Gerasimenko O., Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci. 2005, 25:2429-2433.
11. Cai X.J., Evans M.L., Lister C.A., Leslie R.A., Arch J.R., Wilson S., Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 2001, 50:105-112.
12. Caruso C., Mohn C., Karara A.L., Rettori V., Watanobe H., Schioth H.B., Seilicovich A., Lasaga M. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 2004, 79:278-286.
13. Chen Y., Hu C., Hsu C.K., Zhang Q., Bi C., Asnicar M., Hsiung H.M., Fox N., Slieker L.J., Yang D.D., Heiman M.L., Shi Y. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 2002, 143:2469-2477.
14. Chwalibog A., Jakobsen K., Tauson A.H., Thorbek G. Heat production and substrate oxidation in rats fed at maintenance level and during fasting. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 1998, 121:423-429.
15. Dallaporta M., Pecchi E., Jacques C., Berenbaum F., Jean A., Thirion S., Troadec J.D. c-Fos immunoreactivity induced by intraperitoneal LPS administration is reduced in the brain of mice lacking the microsomal prostaglandin E synthase-1 (mPGES-1). Brain Behav. Immun. 2007, 21:1109-1121.
16. Dantzer R., Konsman J.P., Bluthe R.M., Kelley K.W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?. Auton. Neurosci. 2000, 85:60.
17. Diano S., Horvath B., Urbanski H.F., Sotonyi P., Horvath T.L. Fasting activates the nonhuman primate hypocretin (orexin) system and its postsynaptic targets. Endocrinology 2003, 144:3774-3778.
18. Dunn A.J., Swiergiel A.H. The role of cyclooxygenases in endotoxin- and interleukin-1-induced hypophagia. Brain Behav. Immun. 2000, 14:141-152.
19. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., Flier J.S., Saper C.B., Elmquist J.K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999, 23:775-786.
20. Elias C.F., Saper C.B., Maratos-Flier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., Elmquist J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998, 402:442-459.
21. Elmquist J.K., Scammell T.E., Jacobson C.D., Saper C.B. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J. Comp. Neurol. 1996, 371:85.
22. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 1995, 361:681-698.
23. Felies M., von Horsten S., Pabst R., Nave H. Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats. J. Physiol. 2004, 561:245-252.
24. Fishkin R.J., Winslow J.T. Endotoxin-induced reduction of social investigation by mice: interaction with amphetamine and anti-inflammatory drugs. Psychopharmacology (Berl.) 1997, 132:335.
25. Ford G.K., Al-Barazanji K.A., Wilson S., Jones D.N., Harbuz M.S., Jessop D.S. Orexin expression and function: glucocorticoid manipulation, stress, and feeding studies. Endocrinology 2005, 146:3724-3731.
26. Fujiki N., Yoshida Y., Ripley B., Honda K., Mignot E., Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001, 12:993-997.
27. Gautron L., Mingam R., Moranis A., Combe C., Laye S. Influence of feeding status on neuronal activity in the hypothalamus during lipopolysaccharide-induced anorexia in rats. Neuroscience 2005, 134:933-946.
28. Gaykema R.P., Goehler L.E. Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior. Brain Behav. Immun. 2009.
29. Gayle D., Ilyin S.E., Plata-Salaman C.R. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res. Bull. 1997, 44:311.
30. Gayle D., Ilyin S.E., Plata-Salaman C.R. Feeding status and bacterial LPS-induced cytokine and neuropeptide gene expression in hypothalamus. Am. J. Physiol. 1999, 277:R1188-R1195.
31. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85:49-59.
32. Gonzalez J.A., Jensen L.T., Fugger L., Burdakov D. Metabolism-independent sugar sensing in central orexin neurons. Diabetes 2008.
33. Hansen M.K., Taishi P., Chen Z., Krueger J.M. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J. Neurosci. 1998, 18:2247.
34. Harden L.M., du Plessis I., Poole S., Laburn H.P. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol. Behav. 2006, 89:146-155.
35. Harvey D., Smith R., English K., Mahon B., Commins S. Interleukin-10 (IL-10) but not Lipopolysaccharide (LPS) produces increased motor activity and abnormal exploratory patterns while impairing spatial learning in Balb/c mice. Physiol. Behav. 2006, 87:842-847.
36. Haskell-Luevano C., Chen P., Li C., Chang K., Smith M.S., Cameron J.L., Cone R.D. Characterization of the neuroanatomical distribution of agouti-related protein immunoreactivity in the rhesus monkey and the rat. Endocrinology 1999, 140:1408-1415.
37. Hauser G.J., Myers A.K., Dayao E.K., Zukowska-Grojec Z. Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock. Am. J. Physiol. 1993, 265:H1416.
38. Heyen J.R., Ye S., Finck B.N., Johnson R.W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 2000, 77:138-147.
39. Hollis J.H., Evans A.K., Bruce K.P., Lightman S.L., Lowry C.A. Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons. Brain Behav. Immun. 2006, 20:569-577.
40. Hollis J.H., Lightman S.L., Lowry C.A. Lipopolysaccharide has selective actions on sub-populations of catecholaminergic neurons involved in activation of the hypothalamic-pituitary-adrenal axis and inhibition of prolactin secretion. J. Endocrinol. 2005, 184:393.
41. Huang Q.H., Hruby V.J., Tatro J.B. Systemic alpha-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am. J. Physiol. 1998, 275:R524-R530.
42. Huang Q.H., Hruby V.J., Tatro J.B. Role of central melanocortins in endotoxin-induced anorexia. Am. J. Physiol. 1999, 276:R864-R871.
43. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17(Suppl. 1):S112.
44. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. U S A 1992, 89:9117.
45. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13:24.
46. Kent S., Rodriguez F., Kelley K.W., Dantzer R. Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiol. Behav. 1994, 56:1031-1036.
47. Koldzic-Zivanovic N., Tu H., Juelich T.L., Rady P.L., Tyring S.K., Hudnall S.D., Smith E.M., Hughes T.K. Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata. Brain Behav. Immun. 2006, 20:460-468.
48. Konsman J.P., Dantzer R. How the immune and nervous systems interact during disease-associated anorexia. Nutrition 2001, 17:664.
49. Konsman J.P., Luheshi G.N., Bluthe R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 2000, 12:4434.
50. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
51. Kurose T., Ueta Y., Yamamoto Y., Serino R., Ozaki Y., Saito J., Nagata S., Yamashita H. Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats. Regul. Pept. 2002, 104:145-151.
52. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res. 1999, 818:291.
53. Lacroix S., Rivest S. Functional circuitry in the brain of 89 immune-challenged rats: partial involvement of prostaglandins. J. Comp. Neurol. 1997, 387:307.
54. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J. Neurosci. 1999, 19:10923.
55. Laflamme N., Soucy G., Rivest S. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 2001, 79:648.
56. Lang C.H., Cooney R., Vary T.C. Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. Am. J. Physiol. 1996, 271:E309-E316.
57. Larson S.J. Behavioral and motivational effects of immune-system activation. J. Gen. Psychol. 2002, 129:401.
58. Laye S., Bluthe R.M., Kent S., Combe C., Medina C., Parnet P., Kelley K., Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 1995, 268:R1327.
59. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., Parnet P. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R93-R98.
60. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 1994, 27:157.
61. Ledeboer A., Binnekade R., Breve J.J., Bol J.G., Tilders F.J., Van Dam A.M. Site-specific modulation of LPS-induced fever and interleukin-1 beta expression in rats by interleukin-10. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282:R1762-R1772.
62. Ledeboer A., Breve J.J., Wierinckx A., van der Jagt S., Bristow A.F., Leysen J.E., Tilders F.J., Van Dam A.M. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 2002, 16:1175-1185.
63. Lenczowski M.J., Bluthe R.M., Roth J., Rees G.S., Rushforth D.A., Van Dam A.M., Tilders F.J., Dantzer R., Rothwell N.J., Luheshi G.N. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am. J. Physiol. 1999, 276:R652.
64. Leon L.R., Kozak W., Rudolph K., Kluger M.J. An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 1999, 276:R81-R89.
65. Linthorst A.C., Flachskamm C., Hopkins S.J., Hoadley M.E., Labeur M.S., Holsboer F., Reul J.M. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci. 1997, 17:4448.
66. Ludwig D.S., Tritos N.A., Mastaitis J.W., Kulkarni R., Kokkotou E., Elmquist J., Lowell B., Flier J.S., Maratos-Flier E. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J. Clin. Invest. 2001, 107:379-386.
67. Maier S.F., Goehler L.E., Fleshner M., Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann. N. Y. Acad. Sci. 1998, 840:289.
68. Marsh D.J., Weingarth D.T., Novi D.E., Chen H.Y., Trumbauer M.E., Chen A.S., Guan X.M., Jiang M.M., Feng Y., Camacho R.E., Shen Z., Frazier E.G., Yu H., Metzger J.M., Kuca S.J., Shearman L.P., Gopal-Truter S., MacNeil D.J., Strack A.M., MacIntyre D.E., Van der Ploeg L.H., Qian S. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc. Natl. Acad. Sci. U S A 2002, 99:3240-3245.
69. Mathias S., Schiffelholz T., Linthorst A.C., Pollmacher T., Lancel M. Diurnal variations in lipopolysaccharide-induced sleep, sickness behavior and changes in corticosterone levels in the rat. Neuroendocrinology 2000, 71:375-385.
70. McMahon C.D., Buxton D.F., Elsasser T.H., Gunter D.R., Sanders L.G., Steele B.P., Sartin J.L. Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep. J. Endocrinol. 1999, 161:333.
71. Molina-Holgado F., Grencis R., Rothwell N.J. Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia 2001, 33:97-106.
72. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
73. Moriguchi T., Sakurai T., Nambu T., Yanagisawa M., Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci. Lett. 1999, 264:101-104.
74. Morris B.J. Neuronal localisation of neuropeptide Y gene expression in rat brain. J. Comp. Neurol. 1989, 290:358-368.
75. Morrow J.D., Opp M.R. Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice. Brain Behav. Immun. 2005, 19:40.
76. O'Donohue T.L., Miller R.L., Jacobowitz D.M. Identification, characterization and stereotaxic mapping of intraneuronal alpha-melanocyte stimulating hormone-like immunoreactive peptides in discrete regions of the rat brain. Brain Res. 1979, 176:101-123.
77. Oberholzer A., Oberholzer C., Moldawer L.L. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit. Care Med. 2002, 30:S58-S63.
78. Park S.M., Gaykema R.P., Goehler L.E. How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry. Brain Behav. Immun. 2008.
79. Plata-Salaman C.R. Cytokines and feeding suppression: an integrative view from neurologic to molecular levels. Nutrition 1995, 11:674-677.
80. Pousset F., Cremona S., Dantzer R., Kelley K., Parnet P. Interleukin-4 and interleukin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study. Glia 1999, 26:12-21.
81. Propes M.J., Johnson R.W. Role of corticosterone in the behavioral effects of central interleukin-1 beta. Physiol. Behav. 1997, 61:7.
82. Quan N., Stern E.L., Whiteside M.B., Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. 1999, 93:72.
83. Reyes T.M., Sawchenko P.E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J. Neurosci. 2002, 22:5091.
84. Sagar S.M., Price K.J., Kasting N.W., Sharp F.R. Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res. Bull. 1995, 36:381.
85. Sakurai T. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. CNS Neurol. Disord. Drug Targets 2006, 5:313-325.
86. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
87. Scarlett J.M., Jobst E.E., Enriori P.J., Bowe D.D., Batra A.K., Grant W.F., Cowley M.A., Marks D.L. Regulation of central melanocortin signaling by interleukin-1 beta. Endocrinology 2007, 148:4217-4225.
88. Scarlett J.M., Zhu X., Enriori P.J., Bowe D.D., Batra A.K., Levasseur P.R., Grant W.F., Meguid M.M., Cowley M.A., Marks D.L. Regulation of AgRP mRNA transcription and peptide secretion by acute and chronic inflammation. Endocrinology 2008.
89. Schiltz J.C., Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 2002, 22:5606.
90. Segal-Lieberman G., Bradley R.L., Kokkotou E., Carlson M., Trombly D.J., Wang X., Bates S., Myers M.G., Flier J.S., Maratos-Flier E. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc. Natl. Acad. Sci. U S A 2003, 100:10085-10090.
91. Sergeyev V., Broberger C., Hokfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res. Mol. Brain Res. 2001, 90:93.
92. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998, 396:670-674.
93. Smith E.M., Cadet P., Stefano G.B., Opp M.R., Hughes T.K. IL-10 as a mediator in the HPA axis and brain. J. Neuroimmunol. 1999, 100:140-148.
94. Stefano G.B., Prevot V., Beauvillain J.C., Hughes T.K. Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: evidence for dependence upon nitric oxide production. Neurosci. Lett. 1998, 256:167-170.
95. Strle K., Zhou J.H., Broussard S.R., Venters H.D., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. IL-10 promotes survival of microglia without activating Akt. J. Neuroimmunol. 2002, 122:9-19.
96. Strle K., Zhou J.H., Shen W.H., Broussard S.R., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. Interleukin-10 in the brain. Crit. Rev. Immunol. 2001, 21:427-449.
97. Sugimoto N., Shido O., Sakurada S., Nagasaka T. Day-night variations of behavioral and autonomic thermoregulatory responses to lipopolysaccharide in rats. Jpn. J. Physiol. 1996, 46:451-456.
98. Sutcliffe J.G., de Lecea L. The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 2002, 3:339-349.
99. Szekely M. Orexins, energy balance, temperature, sleep-wake cycle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R530-R532.
100. Urban J.H., Bauer-Dantoin A.C., Levine J.E. Neuropeptide Y gene expression in the arcuate nucleus: sexual dimorphism and modulation by testosterone. Endocrinology 1993, 132:139-145.
101. Ward H., Vigues S., Poole S., Bristow A.F. The rat interleukin 10 receptor: cloning and sequencing of cDNA coding for the alpha-chain protein sequence, and demonstration by western blotting of expression in the rat brain. Cytokine 2001, 15:237-240.
102. Wieczorek M., Swiergiel A.H., Pournajafi-Nazarloo H., Dunn A.J. Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol. Behav. 2005, 85:500-511.
103. Williams L., Bradley L., Smith A., Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 2004, 172:567-576.
104. Wisse B.E., Ogimoto K., Schwartz M.W. Role of hypothalamic interleukin-1beta (IL-1beta) in regulation of energy homeostasis by melanocortins. Peptides 2006, 27:265-273.
105. Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., Sugiura H., Cao C., Watanabe Y., Kobayashi S. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J. Neurosci. 2001, 21:2669.
106. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
107. Zhang Y.H., Lu J., Elmquist J.K., Saper C.B. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain. J. Comp. Neurol. 2003, 463:3.